×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 1.48 | 0.93 | 0.67 | 0.00 | 5.33 | 35.5 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| SANJIVANI PARANTERAL LTD. | 186.08 | 21.94 | 181.81 | 1.62 | 258.0 | 31.8 |
| BAFNA PHARMACEUTICALS LTD. | 352.2 | 33.89 | 346.24 | 1.43 | 258 | 25.6 |
| ASARFI HOSPITAL LIMITED | NA | NA | NA | NA | 249 | 23.5 |
Sanjivani Paranteral Ltd., with Security Code 531569, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.1 | 8.1 | 12.6 | 14.0 | 15.0 | 12.9 | 16.4 | 18.1 | 17.3 | 18.2 |
| Expenses | 8.2 | 6.7 | 10.6 | 11.9 | 13.0 | 10.7 | 14.1 | 15.3 | 14.8 | 15.5 |
| Operating Profit | 0.9 | 1.4 | 2.0 | 2.1 | 2.0 | 2.2 | 2.3 | 2.9 | 2.6 | 2.7 |
| OPM % | 10.12% | 17.56% | 15.99% | 15.1% | 13.09% | 16.78% | 14.22% | 15.74% | 14.7% | 14.67% |
| Other Income | 0.3 | 0.0 | 0.1 | 0.2 | 0.3 | 0.1 | 0.1 | 0.4 | 0.3 | 0.4 |
| Interest | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.2 | 0.2 | 0.2 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 |
| Profit before tax | 1.0 | 1.0 | 1.8 | 2.0 | 1.9 | 1.9 | 2.3 | 2.9 | 2.5 | 2.7 |
| Tax % | 0% | -0.1% | -13.9% | -14.1% | -13.2% | -33.2% | -24.6% | -21.3% | -24.4% | -15% |
| Net Profit | 1.0 | 1.0 | 1.6 | 1.7 | 1.7 | 1.3 | 1.7 | 2.3 | 1.9 | 2.2 |
| EPS in Rs | 0.95 | 1 | 1.55 | 1.71 | 1.65 | 1.08 | 1.47 | 1.96 | 1.62 | 0 |
| Metrics | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|
| Sales | 18.1 | 17.3 | 18.2 |
| Expenses | 15.3 | 14.8 | 15.5 |
| Operating Profit | 2.9 | 2.6 | 2.7 |
| OPM % | 15.74% | 14.7% | 14.67% |
| Other Income | 0.4 | 0.3 | 0.4 |
| Interest | 0.2 | 0.2 | 0.2 |
| Depreciation | 0.1 | 0.2 | 0.2 |
| Profit before tax | 2.9 | 2.5 | 2.7 |
| Tax % | -21.3% | -24.4% | -15.1% |
| Net Profit | 2.3 | 1.9 | 2.2 |
| EPS in Rs | 1.96 | 1.62 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 19% |
| 3 Years: | 33% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 38% |
| 3 Years: | 63% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 105% |
| 3 Years: | 63% |
| 1 Year: | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 105% |
| 3 Years: | 63% |
| 1 Year: | 19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|